35 studies found for:    obstetrics | NICHD
Show Display Options
Rank Status Study
21 Recruiting Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
Condition: HIV Infections
Interventions: Drug: Current ARV medications;   Drug: Current TB medications;   Drug: Current hormonal contraceptive medications
22 Completed Safety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in Thailand
Condition: HIV Infections
Interventions: Drug: GPO-Vir Z30 tablet;   Drug: Lamivudine;   Drug: Nevirapine;   Drug: Zidovudine
23 Completed
Has Results
Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth
Condition: HIV Infections
Interventions: Drug: Didanosine, enteric-coated;   Drug: Lopinavir/ritonavir;   Drug: Nevirapine;   Drug: Zidovudine
24 Completed Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai Children
Condition: HIV Infections
Interventions: Drug: Lamivudine, nevirapine, and stavudine fixed-dose tablet;   Drug: Lamivudine;   Drug: Nevirapine;   Drug: Stavudine
25 Terminated
Has Results
Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Strategy
Condition: HIV Disease
Interventions: Drug: HAART regimen;   Drug: 3TC or FTC monotherapy
26 Completed Safety of Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine/TDF in HIV Infected Pregnant Women and Their Infants
Condition: HIV Infections
Interventions: Drug: Emtricitabine/Tenofovir disoproxil fumarate;   Drug: Tenofovir disoproxil fumarate
27 Completed Safety of and Immune Response to an HIV-1 Vaccine (ALVAC-HIV vCP1521) in Infants Born to HIV Infected Mothers
Condition: HIV Infections
Interventions: Biological: ALVAC-HIV vCP1521;   Biological: ALVAC HIV-1 vCP1521
28 Active, not recruiting Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Conditions: HIV Infections;   Pregnancy Complications, Infectious
Intervention: Behavioral: Adherence assessment
29 Completed Voluntary HIV Counseling, Testing, and Medication for Pregnant Women to Prevent Mother-to-Child HIV Transmission
Condition: HIV Infections
Interventions: Procedure: Intrapartum HIV counseling/testing;   Procedure: Postpartum HIV counseling/testing
30 Completed Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy
Conditions: HIV Infections;   Pregnancy
Interventions: Drug: Lamivudine;   Drug: Lamivudine/Zidovudine;   Drug: Nelfinavir mesylate;   Drug: Nevirapine;   Drug: Zidovudine
31 Completed Oral L-Citrulline and ADMA in Pregnancy
Condition: Blood Pressure
Interventions: Drug: L-citrulline;   Drug: Placebo
32 Completed Safety and Acceptability of a Vaginal Microbicide
Conditions: HIV Infections;   Hepatitis B, Chronic
Intervention: Drug: 1% tenofovir gel
33 Completed
Has Results
Using Nevirapine to Prevent Mother-to-Child HIV Transmission During Breastfeeding
Condition: HIV Infections
Interventions: Drug: Nevirapine;   Drug: Nevirapine placebo
34 Completed Blood Levels of Tenofovir Gel in HIV Uninfected Pregnant Women Planning Cesarean Delivery
Condition: HIV Infections
Intervention: Drug: Tenofovir 1% vaginal gel
35 Completed BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in Women
Condition: HIV Infections
Interventions: Drug: BufferGel;   Drug: PRO 2000/5 Gel;   Drug: Placebo gel

Show previous page of results Previous Page (1-20) Studies Shown (21-35) Next Page
Indicates status has not been verified in more than two years